Products

What will AGI do for Arotinolol hydrochloride?

This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H21N3O2S3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9DOI1HT306, chemically known as 2-thiophenecarboxamide, 5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-, monohydrochloride, (+-)- but more generally known as arotinolol hydrochloride, which bears US NIH Compound Identifier 155032. European Medicines Agency schedules Arotinolol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00590MIG. Most nations, for tariff and trade purposes, schedule arotinolol hydrochloride under HS 29341000 and SITC 51579. As of Q4 2014, AROTINOLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(C)(C)NCC(CSC1NC(CS1)C2CCC(S2)C(=O)N)O.CL.

How AGI delivers it

Four ways AGI delivers for Arotinolol hydrochloride

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Arotinolol hydrochloride, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Arotinolol hydrochloride, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Arotinolol hydrochloride connects

measured by

  • Assaymodel
  • Assay Puritymodel
  • Chloride Contentmodel
  • Loss On Dryingmodel
  • Particle Size Distributionmodel
  • Puritymodel
  • Residual Solventmodel